Literature DB >> 16424087

Ankyrin repeat and SOCS box protein 15 regulates protein synthesis in skeletal muscle.

T G McDaneld1, K Hannon, D E Moody.   

Abstract

Ankyrin repeat and SOCS box protein 15 (ASB15) is an Asb family member expressed predominantly in skeletal muscle. We have previously reported that ASB15 mRNA abundance decreases after administration of beta-adrenergic receptor agonists. Because beta-adrenergic receptor agonists are known to stimulate muscle hypertrophy, the objective of this study was to determine whether ASB15 regulates cellular processes that contribute to muscle growth. Stable myoblast C2C12 cells expressing full-length ASB15 (ASB15-FL) and ASB15 lacking the ankyrin repeat (ASB15-Ank) or SOCS box (ASB15-SOCS) motifs were evaluated for changes in proliferation, differentiation, protein synthesis, and protein degradation. Expression of ASB15-FL caused a delay in differentiation, followed by an increase in protein synthesis of approximately 34% (P<0.05). A consistent effect of ASB15 overexpression was observed in vivo, where ectopic expression of ASB15 increased skeletal muscle fiber area (P<0.0001) after 9 days. Expression of ASB15-SOCS altered differentiation of myoblasts, resulting in detachment of cells from culture plates. Expression of ASB15-Ank increased protein degradation by 84 h of differentiation (P<0.05), and in vivo ectopic expression of an ASB15 construct lacking both the ankyrin repeat and SOCS box motifs decreased skeletal muscle fiber area (P<0.0001). Together, these results suggest ASB15 participates in the regulation of protein turnover and muscle cell development by stimulating protein synthesis and regulating differentiation of muscle cells. This is the first study to demonstrate a role for an Asb family member in skeletal muscle growth.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16424087     DOI: 10.1152/ajpregu.00239.2005

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  14 in total

1.  The E3 ubiquitin ligase specificity subunit ASB2α targets filamins for proteasomal degradation by interacting with the filamin actin-binding domain.

Authors:  Ziba Razinia; Massimiliano Baldassarre; Mohamed Bouaouina; Isabelle Lamsoul; Pierre G Lutz; David A Calderwood
Journal:  J Cell Sci       Date:  2011-07-12       Impact factor: 5.285

2.  asb11 is a regulator of embryonic and adult regenerative myogenesis.

Authors:  Jin-Ming Tee; Maria A Sartori da Silva; Agnieszka M Rygiel; Vanesa Muncan; Robert Bink; Gijs R van den Brink; Paula van Tijn; Danica Zivkovic; Liudmila L Kodach; Daniele Guardavaccaro; Sander H Diks; Maikel P Peppelenbosch
Journal:  Stem Cells Dev       Date:  2012-06-07       Impact factor: 3.272

3.  Transcriptomic effects of adenosine 2A receptor deletion in healthy and endotoxemic murine myocardium.

Authors:  Kevin J Ashton; Melissa E Reichelt; S Jamal Mustafa; Bunyen Teng; Catherine Ledent; Lea M D Delbridge; Polly A Hofmann; R Ray Morrison; John P Headrick
Journal:  Purinergic Signal       Date:  2016-09-30       Impact factor: 3.765

4.  ASB9 interacts with ubiquitous mitochondrial creatine kinase and inhibits mitochondrial function.

Authors:  Sanghoon Kwon; Dongbum Kim; Jae Won Rhee; Jeong-A Park; Dae-Won Kim; Doo-Sik Kim; Younghee Lee; Hyung-Joo Kwon
Journal:  BMC Biol       Date:  2010-03-19       Impact factor: 7.431

5.  Comparative gene expression profiling between human cultured myotubes and skeletal muscle tissue.

Authors:  Frederic Raymond; Sylviane Métairon; Martin Kussmann; Jaume Colomer; Andres Nascimento; Emma Mormeneo; Cèlia García-Martínez; Anna M Gómez-Foix
Journal:  BMC Genomics       Date:  2010-02-22       Impact factor: 3.969

6.  The E3 ubiquitin ligase specificity subunit ASB2beta is a novel regulator of muscle differentiation that targets filamin B to proteasomal degradation.

Authors:  N F Bello; I Lamsoul; M L Heuzé; A Métais; G Moreaux; D A Calderwood; D Duprez; C Moog-Lutz; P G Lutz
Journal:  Cell Death Differ       Date:  2009-03-20       Impact factor: 15.828

7.  Genome-wide association study of short-acting β2-agonists. A novel genome-wide significant locus on chromosome 2 near ASB3.

Authors:  Elliot Israel; Jessica Lasky-Su; Amy Markezich; Amy Damask; Stanley J Szefler; Brooke Schuemann; Barbara Klanderman; Jody Sylvia; Shamsah Kazani; Rongling Wu; Fernando Martinez; Homer A Boushey; Vernon M Chinchilli; Dave Mauger; Scott T Weiss; Kelan G Tantisira
Journal:  Am J Respir Crit Care Med       Date:  2015-03-01       Impact factor: 30.528

8.  Essential role for the d-Asb11 cul5 Box domain for proper notch signaling and neural cell fate decisions in vivo.

Authors:  Maria A Sartori da Silva; Jin-Ming Tee; Judith Paridaen; Anke Brouwers; Vincent Runtuwene; Danica Zivkovic; Sander H Diks; Daniele Guardavaccaro; Maikel P Peppelenbosch
Journal:  PLoS One       Date:  2010-11-19       Impact factor: 3.240

9.  Gene expression profiling in gastric mucosa from Helicobacter pylori-infected and uninfected patients undergoing chronic superficial gastritis.

Authors:  Ze-Min Yang; Wei-Wen Chen; Ying-Fang Wang
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

10.  Expression profiling of skeletal muscle following acute and chronic beta2-adrenergic stimulation: implications for hypertrophy, metabolism and circadian rhythm.

Authors:  Michael A Pearen; James G Ryall; Gordon S Lynch; George Eo Muscat
Journal:  BMC Genomics       Date:  2009-09-23       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.